New Chair of European Pharmacopoeia Commission Elected

From DCAT Value Chain Insights (VCI)

By Regulatory News posted 03-31-2016 14:20


The European Pharmacopoeia (Ph. Eur.) Commission elected Dr Tobias Gosdschan as its chair for a term from June 2016 to June 2019. He will become the 18th chair of the Ph. Eur. Commission since its establishment in 1964. Dr Gosdschan will be supported by two new vice chairs to be elected in June. Together they will guide the work of the Commission for the three coming years.

Dr Gosdschan holds a PhD in Pharmacy from the University of Basel and is head of the Pharmacopoeia Division at Swissmedic, the Swiss regulatory agency. In this function he is head of the Swiss Delegation to the Ph. Eur. Commission and chair of the Swiss Pharmacopoeia Commission. Furthermore, Dr Gosdschan is a member of the Pharmaceutical Preparations (PHP) and Rules of Procedures (ROP) Working Parties of the Ph. Eur. In 2013 he was elected 1st vice chair of the Ph. Eur. Commission for a mandate of three years.

Source: European Directorate for the Quality of Medicines & HealthCare (EDQM)


Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT). 

Learn more and sign up to receive a complimentary subscription